Nwam LLC purchased a new stake in The Clorox Company (NYSE:CLX – Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund purchased 1,775 shares of the company’s stock, valued at approximately $289,000.
Other institutional investors have also made changes to their positions in the company. Prospera Private Wealth LLC acquired a new stake in Clorox during the third quarter worth about $27,000. Innealta Capital LLC acquired a new stake in shares of Clorox during the 2nd quarter worth approximately $30,000. Trifecta Capital Advisors LLC increased its stake in Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock valued at $30,000 after acquiring an additional 130 shares during the last quarter. Quarry LP raised its position in Clorox by 99.1% during the second quarter. Quarry LP now owns 229 shares of the company’s stock valued at $31,000 after purchasing an additional 114 shares in the last quarter. Finally, Family Firm Inc. bought a new stake in Clorox during the second quarter worth $31,000. 78.53% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
CLX has been the topic of several recent analyst reports. Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and lifted their price target for the company from $174.00 to $187.00 in a research note on Tuesday, October 1st. TD Cowen raised Clorox from a “sell” rating to a “hold” rating and boosted their target price for the stock from $155.00 to $170.00 in a research note on Wednesday, November 6th. JPMorgan Chase & Co. raised their price target on shares of Clorox from $148.00 to $174.00 and gave the company a “neutral” rating in a research note on Friday, October 11th. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. Finally, DA Davidson raised their target price on shares of Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research report on Monday, November 4th. Five equities research analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $155.00.
Insider Buying and Selling
In related news, EVP Angela C. Hilt sold 1,733 shares of the company’s stock in a transaction dated Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares in the company, valued at $2,229,719.92. This represents a 11.40 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. 0.57% of the stock is owned by insiders.
Clorox Stock Down 1.8 %
Shares of NYSE:CLX opened at $166.32 on Tuesday. The firm has a market cap of $20.59 billion, a P/E ratio of 57.95, a P/E/G ratio of 3.13 and a beta of 0.41. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.35. The business has a fifty day simple moving average of $162.79 and a 200 day simple moving average of $148.71. The company has a quick ratio of 0.62, a current ratio of 1.00 and a debt-to-equity ratio of 11.08.
Clorox (NYSE:CLX – Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.36 by $0.50. The company had revenue of $1.76 billion during the quarter, compared to the consensus estimate of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The firm’s revenue was up 27.0% compared to the same quarter last year. During the same period last year, the company earned $0.49 earnings per share. Analysts predict that The Clorox Company will post 6.85 earnings per share for the current year.
Clorox Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Wednesday, January 29th will be given a dividend of $1.22 per share. This represents a $4.88 annualized dividend and a dividend yield of 2.93%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is presently 170.04%.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Articles
- Five stocks we like better than Clorox
- Basic Materials Stocks Investing
- Abacus Life’s CEO on Cracking the Code of Longevity Returns
- 3 Natural Gas Stocks That Offer Great Dividend Yields
- Elon Musk and Trump Push for Self-Driving Cars: 3 Stocks to Gain
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Discover the 3 Best Performing Stocks That Went Public in 2024
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.